BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 5014367)

  • 1. Immunologic unreactivity in bladder cancer patients.
    Olsson CA; Rao CN; Menzoian JO; Byrd WE
    J Urol; 1972 Apr; 107(4):607-9. PubMed ID: 5014367
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunologic reduction of bladder cancer recurrence rate.
    Olsson CA; Chute R; Rao CN
    Trans Am Assoc Genitourin Surg; 1973; 65():66-72. PubMed ID: 4763514
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunologic reduction of bladder cancer recurrence rate.
    Olsson CA; Chute R; Rao CN
    J Urol; 1974 Feb; 111(2):173-6. PubMed ID: 4810758
    [No Abstract]   [Full Text] [Related]  

  • 4. Immune response in bladder cancer patients.
    Brosman S; Elhilali M; Vescera C; Fahey J
    J Urol; 1979 Feb; 121(2):162-9. PubMed ID: 423328
    [No Abstract]   [Full Text] [Related]  

  • 5. Reduced in vivo cell-mediated immune responses to mumps, tuberculin, and streptokinase/streptodornase but not to Candida albicans in oral lichen planus.
    Simark-Mattsson C; Jontell M; Bergenholtz G; Dahlgren UI
    J Dent Res; 1999 Nov; 78(11):1704-10. PubMed ID: 10576166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological responsiveness in patients with bladder cancer.
    Fahey JL; Brosman S; Dorey F
    Cancer Res; 1977 Aug; 37(8 Pt 2):2875-8. PubMed ID: 872117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed hypersensitivity reactions in patients with squamous cell cancer of the head and neck.
    Lundy J; Wanebo H; Pinsky C; Strong E; Oettgen H
    Am J Surg; 1974 Oct; 128(4):530-3. PubMed ID: 4429642
    [No Abstract]   [Full Text] [Related]  

  • 8. Newer concepts of cancer of the colon and rectum: delayed hypersensitivity responses of patients with carcinoma of the colon and other solid tumors.
    Kronman BS; Shapiro HM; Localio SA
    Dis Colon Rectum; 1972; 15(2):106-10. PubMed ID: 5026786
    [No Abstract]   [Full Text] [Related]  

  • 9. Skin tests with soluble tumor membrane antigens in patients with transitional cell cancers.
    Hollinshead AC
    Natl Cancer Inst Monogr; 1978 Dec; (49):255-6. PubMed ID: 748779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anergy and tryptophan metabolism in bladder cancer.
    Romas NA; Ionascu L; Ionescu G; Wechsler M; Tannenbaum M; Veenema RJ
    J Urol; 1976 Apr; 115(4):387-9. PubMed ID: 1263311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed hypersensitivity to tuberculin and other antigens in a hospital population.
    Walls RS
    S Afr Med J; 1974 Oct; 48(49):2073-6. PubMed ID: 4609390
    [No Abstract]   [Full Text] [Related]  

  • 12. [Delayed skin reaction in a group of 400 hospital patients: control study (author's transl)].
    Orriols R; Morell F; Fité E; Ruiz J; Tornos C; Sanz R; Morera J
    Med Clin (Barc); 1981 Oct; 77(6):240-2. PubMed ID: 7321638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnostic and prognostic significance of delayed hypersensitivity skin testing in patients with urological cancer.
    Williams G; Castro JE
    Br J Urol; 1975 Feb; 47(1):97-101. PubMed ID: 1131501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular cytotoxicity in vitro in transitional cell carcinoma of the human urinary bladder: 51Cr-release assay.
    Troye M; Perlmann P; Larsson A; Blomgren H; Johansson B
    Int J Cancer; 1977 Aug; 20(2):188-98. PubMed ID: 892930
    [No Abstract]   [Full Text] [Related]  

  • 15. Cellular immunity in bladder cancer patients.
    Guinan P; McKiel C; Flanagan M; Bhatti R; Pessis D; Ablin RJ
    J Urol; 1978 Jun; 119(6):747-9. PubMed ID: 660759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune response in bladder cancer.
    Merrin C; Han T
    J Urol; 1974 Feb; 111(2):170-2. PubMed ID: 4810757
    [No Abstract]   [Full Text] [Related]  

  • 17. Immediate and delayed hypersensitivity in chronic dermatophytosis.
    Sorensen GW; Jones HE
    Arch Dermatol; 1976 Jan; 112(1):40-2. PubMed ID: 129033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed cutaneous hypersensitivity and peripheral lymphocyte counts in patients with advanced cancer.
    Lee YT; Sparks FC; Eilber FR; Morton DL
    Cancer; 1975 Mar; 35(3):748-55. PubMed ID: 1111942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The macrophage aggregation assay for cell-mediated immunity in man. Studies of patients with Hodgkin's disease and sarcoidosis.
    Gotoff SP; Lolekha S; Lopata M; Kopp J; Kopp RL; Malecki TJ
    J Lab Clin Med; 1973 Oct; 82(4):682-91. PubMed ID: 4585463
    [No Abstract]   [Full Text] [Related]  

  • 20. Delayed cutaneous hypersensitivity reactions to tumor cell antigens and to nonspecific antigens. Prognostic significance in patients with lung cancer.
    Wells SA; Burdick JF; Joseph WL; Christiansen CL; Wolfe WG; Adkins PC
    J Thorac Cardiovasc Surg; 1973 Oct; 66(4):557-62. PubMed ID: 4755446
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.